Why This Marijuana Stock Crashed 18.5% in August

Why This Marijuana Stock Crashed 18.5% in August

Arizona's attorney general is suing Insys Therapeutics (NASDAQ: INSY) over its marketing of the fentanyl opioid spray, Subsys, and that news caused the company's shares to tumble 18.5% in August, according to S&P Global Market Intelligence.

Insys Therapeutics has launched its marijuana drug Syndros. However, uncertainty over demand for it and ongoing concerns regarding the marketing of Subsys remain major headwinds.

IMAGE SOURCE: INSYS THERAPEUTICS.

Continue reading

Source: Fool.com